EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 11 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,616,000 | $2,214,000 | 0.28% |
| SABBY MANAGEMENT, LLC | 345,524 | $473,000 | 0.03% |
| Vantage Investment Advisors, LLC | 6,500 | $9,000 | 0.00% |
| IFP Advisors, Inc | 15,800 | $22,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 500 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 200 | $0 | 0.00% |
| MORGAN STANLEY | 1,220 | $1,000 | 0.00% |
| BlackRock Inc. | 635 | $1,000 | 0.00% |
| Creative Planning | 300 | $0 | 0.00% |